RADx Webinar Series: Delivering New Rapid Technologies for the Diverse US Market - POCTRN

Center news

null RADx Webinar Series: Delivering New Rapid Technologies for the Diverse US Market

RADx Tech Webinar Series: Delivering New COVID-19 Technologies to Close the Testing Gap in the US Market

Watch the three part series

RADxsm Tech Webinar Series: Delivering New COVID-19 Technologies to Close the Testing Gap in the US Market

Please join us for an informative three-part webinar series that will present NIH’s RADx Tech Program (RADxsm) and how it is being leveraged to accelerate the innovation pipeline of technology and deploy them to meet today's most pressing health needs in resolving the COVID-19 pandemic.

Session 1: How RADxsm Tech Will Address the Unmet US Market COVID-19 Testing Needs

October 13, 2020
2:00PM EST

This session will review the current and projected testing capacity needs, the current unmet market needs for the various customer segments in the United States. We also will describe the unique approach of the Rapid Acceleration of Diagnostics (RADx) program, its goals, and its focus on how it works to meet the demand for diagnostic testing for COVID-19. The session will also provide insights into the complexity and factors that drive the choice and usage of these tests.


Steven Schachter, MD

Manuel Kingsley, RADx Team Lead

Watch the Recording

Download the Slides

Session 2: RADxsm Tech Portfolio of Technologies 

October 20, 2020 
2:00PM EST

The current diagnosis of acute SARS-CoV-2 infection relies on tests that detect either viral RNA or viral antigens. We will explore the currently marketed gold standard COVID-19 tests. We also will review the different types of novel sample and detection technologies being developed and funded by RADx program that have the potential of revolutionizing testing for SARS-CoV-2 in the USA. The session will offer an assessment on how these technologies can help improve the COVID-19 testing capacity in the US.


Dr. Daniel Marshak, PhD
CIMIT Consultant

Watch the Recording

Download the Slides

Session 3 
Closing the Testing Gap: A Panel Discussion on the Emerging Innovative Technologies and their Impact on Current Testing Challenges

October 27, 2020 
2:30PM EST (Please Note Change in Start Time)

In this third session, a panel of interdisciplinary speakers will discuss the various testing technologies, testing frequency, location, and turnaround time, and impact on the COVID-19 pandemic in diverse vulnerable populations, academic institutions, and business.


Dr. Bruce Tromberg, PhD
National Institute of Biomedical Imaging and Bioengineering (NIBIB)


Sara Brenner, MD, MPH
Associate Director for Medical Affairs, FDA, Center for Devices and Radiological Health

Nancy Gagliano, MD, MBA  
RADx Core Leader, Large Scale Deployment

Yukari Manabe, MD  
Principal Investigator, JHU Center for Point-of-Care Technologies Research for Sexually Transmitted Diseases
Professor of Medicine in the Division of Infectious Diseases, Associate Director of Global Health Research and Innovation, Johns Hopkins University School of Medicine

Dr. Rangarajan Sampath
Chief Scientific Officer, Foundation for Innovative New Diagnostics (FIND)

View the Recording

RADx: Rapid Acceleration of Diagnostics

In response to the COVID-19 pandemic, the Rapid Acceleration of Diagnostics (RADx®) initiative was formed to accelerate the development, validation, and commercialization of innovative point-of-care and home-based tests, as well as improvements to clinical laboratory tests, that can directly detect SARS-CoV-2, the virus that causes COVID-19.


In the News 

Two New Over-the-Counter At-Home COVID-19 Tests Brought to U.S. Market Quickly by Biden-Harris Administration

New HHS actions add to Biden administration efforts to increase access to easy-to-use over-the-counter COVID-19 tests

NIH RADx initiative expands COVID-19 testing innovation for additional types of rapid tests

The need for new test verification and regulatory support for innovative diagnostics

NIH-funded screening study builds case for frequent COVID-19 antigen testing

RADx partnerships speed new COVID testing

One Year of RADx Tech Success

Publication reveals essential ingredients of the groundbreaking NIH RADx national diagnostics effort 

Innovative COVID-19 Testing RADx Tech Reports Unveiled in Special Issue of IEEE Open Journal of Engineering in Medicine and Biology

Luminostics Announces FDA Authorization and Production Scale-Up of US-Manufactured Smartphone-Based COVID-19 Rapid Test

RADx Expects COVID-19 Portfolio to Accelerate an Era of At-Home Infectious Disease Testing (Login Required)

VIC Foundry, Inc. Receives NIH RADx Funding for Development of an At-home Molecular Diagnostic Test for COVID-19

Ceres Nanosciences Opens Advanced Particle Manufacturing Plant in Northern Virginia to Expand Nanotrap® Particle Manufacturing Capacity for COVID-19 Testing

COVID-19 Testing: Three Breakthrough Solutions in the RADx Initiative

NIH Director: Collaboration Amid Chaos, and Biden’s First 100 Days - How Francis Collins sees the COVID response changing with the new administration

The National Strategy From the COVID-19 Response and Pandemic Preparedness

Winners of HHS Design-a-thon to Develop Innovative Digital Health Tools for COVID-19 At-Anywhere Diagnostic Tests Announced

The Need for More and Better Testing for COVID-19